Get started
222

ST PHARM CO., LTD.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

237690 chart


Full chart

Key stats


Market capitalization
‪1.72 T‬ KRW
Dividend yield (indicated)
0.60%
Price to earnings Ratio (TTM)
100
Basic EPS (TTM)
1,700 KRW
Net income (FY)
‪19.58 B‬ KRW
Revenue (FY)
‪284.99 B‬ KRW
Shares float
‪12.14 M‬
Beta (1Y)
1.05

Employees


Employees (FY)
669
Change (1Y)
+30 +4.69%
Revenue / Employee (1Y)
‪327.17 K‬ KRW
Net income / Employee (1Y)
‪22.48 K‬ KRW

About ST PHARM CO., LTD.


Sector
Health Technology
CEO
Gyeong-Jin Kim
Headquarters
Siheung
Website
stpharm.co.kr
Founded
1983
ISIN
KR7237690003
FIGI
BBG00CX93J57
ST Pharm Co., Ltd. develops and manufactures pharmaceutical products. It operates throught the following business divisions: New Drug Contract Manufacturing Organization (CMO), Generic Active Pharmaceutical Ingredients (APIs), Fine Chemical, and Bio. The New Drug CMO business offers services such as process optimization, documentation support, and validation. The Generic APIs business produces APIs for anti-cancer, tubeculosis, coagulant, and fungal, asthma, diabetes mellitus, hepatitis B, and Epilepsy treating drugs. The Fine Chemical business offers pharmaceutical intermediates. The Bio business develops and produces ribonucleic acid therapeutics and phosphoamidite monomers. The company was founded in 1983 and is headquartered in Siheung, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

237690 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 237690 is 83,200 KRW — it has decreased by −2.92% in the past 24 hours. Watch ST PHARM CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ST PHARM CO., LTD. stocks are traded under the ticker 237690.
237690 stock has fallen by −7.45% compared to the previous week, the month change is a −18.35% fall, over the last year ST PHARM CO., LTD. has showed a 21.28% increase.
We've gathered analysts' opinions on ST PHARM CO., LTD. future price: according to them, 237690 price has a max estimate of 130,000.00 KRW and a min estimate of 118,000.00 KRW. Watch 237690 chart and read a more detailed ST PHARM CO., LTD. stock forecast: see what analysts think of ST PHARM CO., LTD. and suggest that you do with its stocks.
237690 reached its all-time high on Dec 29, 2021 with the price of 150,800 KRW, and its all-time low was 12,300 KRW and was reached on Aug 6, 2019. View more price dynamics on 237690 chart.
See other stocks reaching their highest and lowest prices.
237690 stock is 4.47% volatile and has beta coefficient of 1.05. Track ST PHARM CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is ST PHARM CO., LTD. there?
Today ST PHARM CO., LTD. has the market capitalization of ‪1.67 T‬, it has decreased by −5.41% over the last week.
Yes, you can track ST PHARM CO., LTD. financials in yearly and quarterly reports right on TradingView.
ST PHARM CO., LTD. revenue for the last quarter amounts to ‪61.20 B‬ KRW, despite the estimated figure of ‪61.70 B‬ KRW. In the next quarter, revenue is expected to reach ‪133.05 B‬ KRW.
237690 net income for the last quarter is ‪14.61 B‬ KRW, while the quarter before that showed ‪1.01 B‬ KRW of net income which accounts for ‪1.35 K‬% change. Track more ST PHARM CO., LTD. financial stats to get the full picture.
Yes, 237690 dividends are paid annually. The last dividend per share was 500.00 KRW. As of today, Dividend Yield (TTM)% is 0.60%. Tracking ST PHARM CO., LTD. dividends might help you take more informed decisions.
ST PHARM CO., LTD. dividend yield was 0.74% in 2023, and payout ratio reached 48.03%. The year before the numbers were 0.57% and 52.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 23, 2024, the company has 669.00 employees. See our rating of the largest employees — is ST PHARM CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ST PHARM CO., LTD. EBITDA is ‪51.54 B‬ KRW, and current EBITDA margin is 18.97%. See more stats in ST PHARM CO., LTD. financial statements.
Like other stocks, 237690 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ST PHARM CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ST PHARM CO., LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ST PHARM CO., LTD. stock shows the neutral signal. See more of ST PHARM CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.